RhumbLine Advisers’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,437
Closed -$150K 4382
2024
Q1
$150K Buy
3,437
+82
+2% +$3.4K ﹤0.01% 3302
2023
Q4
$137K Buy
3,355
+39
+1% +$2.12K ﹤0.01% 3347
2023
Q3
$275K Sell
3,316
-229
-6% -$20.8K ﹤0.01% 2976
2023
Q2
$337K Buy
3,545
+148
+4% +$19K ﹤0.01% 2940
2023
Q1
$469K Sell
3,397
-2
-0.1% -$183 ﹤0.01% 2464
2022
Q4
$243K Buy
3,399
+60
+2% +$5.68K ﹤0.01% 2738
2022
Q3
$394K Buy
3,339
+201
+6% +$35.8K ﹤0.01% 2606
2022
Q2
$572K Buy
3,138
+959
+44% +$174K ﹤0.01% 2427
2022
Q1
$511K Buy
2,179
+279
+15% +$56.3K ﹤0.01% 2418
2021
Q4
$648K Buy
1,900
+301
+19% +$166K ﹤0.01% 2402
2021
Q3
$1.04M Buy
1,599
+41
+3% +$30.1K ﹤0.01% 2212
2021
Q2
$1.56M Buy
+1,558
New +$1.55M ﹤0.01% 2062

Other funds holding DNMR

RhumbLine Advisers's DNMR Position: Q2 2024 in Review

RhumbLine Advisers sold out of Danimer Scientific, Inc. (DNMR) in Q2 2024, closing a stake of 3,437 shares — an estimated $150K sold.

RhumbLine Advisers first reported a position in DNMR in Q2 2021 and held it in 12 quarters. The position peaked at $1.56M in Q2 2021. 139 funds tracked by Wall St. Rank hold DNMR as of Q2 2024.

  • RhumbLine Advisers reported no remaining Danimer Scientific, Inc. position as of Q2 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 3,437 Danimer Scientific, Inc. shares in Q2 2024, an estimated $150K.
  • RhumbLine Advisers first reported a position in Danimer Scientific, Inc. in Q2 2021 and held it in 12 quarters.
  • RhumbLine Advisers's Danimer Scientific, Inc. position peaked at $1.56M in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q2 2024.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.